Home / Pharmaceuticals / Antihistamines Market By Antihistamines Type (First Generation Antihistamines, Second Generation Antihistamines), By Application (Allergic Rhinitis, Conjunctivitis, Urticaria, Atopic Dermatitis, Anaphylaxis, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Antihistamines Market By Antihistamines Type (First Generation Antihistamines, Second Generation Antihistamines), By Application (Allergic Rhinitis, Conjunctivitis, Urticaria, Atopic Dermatitis, Anaphylaxis, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Published: Jul 2018 | Report Code: 59231-07-18

Industry Outlook

The global antihistamines market will grow at a CAGR of 8.7% during the forecast period from 2018 to 2026. Antihistamines exemplify a class of drugs that block the histamine type-1 (H1) receptors. H1-receptors are extensively scattered and predominantly found on smooth muscle of the gastrointestinal tract, bronchi, uterus, and large blood vessels. The key applications of antihistamines are allergic rhinitis, conjunctivitis, urticaria, atopic dermatitis, anaphylaxis, and others. In year 2016 according to European Academy of Allergy and Clinical Immunology (EAACI), around 150 million or more Europeans suffer from chronic allergic conditions and further anticipated that by 2025 half of the total population of Europe will suffer with chronic allergic diseases. Thus, rising global prevalence of allergies expected to increase the demand for antihistamines in the near future.

Market Synopsis

Antihistamines Market

Second-generation antihistamines expected to retain its market dominance during the forecast period

Second-generation antihistamines such as acrivastine, cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine are preferred as first-line of treatment in diseases such as allergic rhinitis, urticaria, and atopic dermatitis. The key factors assisting the growth of second-generation antihistamines are rising prevalence of allergies, increasing awareness related to early diagnosis & treatment of allergies, and overall development in the treatment technology. However, the main reason for prescribing second-generation antihistamines is there are very few second-generation antihistamines that cross blood-brain barrier and have sedating effect. Cetirizine causes drowsiness that may lead to accidents with people driving car or handling heavy machinery. Thus, levocetirizine is now preferred over cetirizine due to its non-sedating effect. Second-generation antihistamines possess a longer duration of action and plasma half-life compared to first generation drugs, which makes it easy to decrease the number of daily intakes.

Antihistamines Market

Asia Pacific will exhibit double-digit growth during the forecast period due to increasing patient awareness related to allergic reactions

Asia Pacific observed as the fastest growing region in antihistamines market due to rising awareness in patients and medical practitioners related to allergic conditions, and developing digital healthcare infrastructure. According to World Allergy Organization (WAO), prevalence of allergic diseases is increasing globally, including in the Asia-Pacific region. The published report of WAO suggest that in 2016, 20% to 30% of the world’s population suffered from some or other form of allergic conditions. The market experts believe that physicians in Asia-Pacific have access to all available second-generation H1- antihistamines due to which they are able to follow international guideline recommendations for first-line treatment of allergic rhinitis and urticaria effectively. Thus, overall awareness related to early diagnosis and treatment of allergy conditions have assisted the growth of antihistamines in Asia Pacific region specifically in developing countries such as India & China.

Antihistamines Market

Antihistamines in pipeline are on the verge of exploring several other applications

Antihistamines in phase III of clinical trials are exploring applications such as chronic spontaneous urticaria, angioedema, functional dyspepsia, hemodynamic instability, vasoplegic syndrome, elbow injury, and others. Thus, post approvals for these applications antihistamine market will grow exponentially during the forecast period from 2018 to 2026. The major companies equipped with antihistamines under pipeline are Novartis AG, Celgene Corporation, F. Hoffman-La Roche, Genzyme (Sanofi), Ache Laboratorios Farmaceuticos S.A., Merck & Co. Inc., and Faes Farma, S.A. Thus, strong pipeline expected to boost the overall growth of antihistamines market throughout the forecast period.

Antihistamines Market

Historical & Forecast Period

2016 – Historical Year

2017 – Base Year

2018-2026 – Forecast Period

The antihistamines market analyzed considering current market trends for base year 2017 and based on future trends CAGRs calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report on antihistamines market offers in-depth information related to market dynamics and global trends. The report provides comprehensive summary of the global antihistamines market by segmenting the market based on type of antihistamines and geography. The objective of publishing this in-depth research report is to assist the industry stakeholders in carrying-out decisions and strategy implementation in the antihistamines market.

Antihistamines Market

Antihistamines Type Segment (2016–2026; US$ Mn)

  • First-Generation Antihistamines
    • Alimemazine
    • Chlorphenamine
    • Clemastine
    • Cyproheptadine
    • Hydroxyzine
    • Ketotifen
    • Promethazine
    • Others(Carbinoxamine, Dimenhydrinate, and others)
  • Second-Generation Antihistamines
    • Acrivastine
    • Cetirizine
    • Desloratadine
    • Fexofenadine
    • Levocetirizine
    • Loratadine

Application Segment (2016–2026; US$ Mn)

  • Allergic Rhinitis
  • Conjunctivitis
  • Urticaria
  • Atopic Dermatitis
  • Anaphylaxis
  • Others (Angioedema, Pruritus, and others)

Geography Segment (2016–2026; US$ Mn)

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • GCC
    • Rest of MEA

This report further describes the major qualitative assessment factors including key market trends, market drivers & restraints, to assist in better understanding of global antihistamines market. Furthermore, the key players are analyzed graphically based on their product offering, market strategies and business strength. The report also provides attractive investment proposition based on the extensive geographical research carried out based on PESTEL analysis. Key players profiled in the report include Bayer AG, Almirall S.A., Johnson & Johnson, AstraZeneca plc, Novartis AG, Pfizer, Inc., Sanofi SA, Boehringer Ingelheim GmbH, Merck & Co., Inc., Akorn, Inc., Teva Pharmaceutical Industries Ltd., and others.

Key questions answered in this report

  • Which are the most preferred drugs prescribed as the first line of treatment in allergic conditions?
  • What will be the effect of pipeline products approval in key markets such as North America, Europe & Asia Pacific?
  • What are the recent market developments in the antihistamine industry and valuable growth opportunities for the players?
  • Which are the most promising pipeline drugs in phase III clinical trials?
  • Which geographical markets are suitable for new product launch?
  • What is the market size of North America, and where other regional markets stand in the global competition?
  • Which are the major countries in Asia Pacific antihistamines market considered promising during the geographical expansion?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Antihistamines Market Portraiture
2.2. Global Antihistamines Market, by Antihistamines Type, 2017 (US$ Mn)
2.3. Global Antihistamines Market, by Application, 2017 (US$ Mn)
2.4. Global Antihistamines Market, by Geography, 2017 (US$ Mn)

Chapter 3. Antihistamines: Market Dynamics and Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Antihistamines Market, by Key Players, 2017

Chapter 4. Global Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
4.1. Overview
4.2. First Generation Antihistamines
4.2.1. Alimemazine
4.2.2. Chlorphenamine
4.2.3. Clemastine
4.2.4. Cyproheptadine
4.2.5. Hydroxyzine
4.2.6. Ketotifen
4.2.7. Promethazine
4.2.8. Others(Carbinoxamine, Dimenhydrinate, and others)
4.3. Second Generation Antihistamines
4.3.1. Acrivastine
4.3.2. Cetirizine
4.3.3. Desloratadine
4.3.4. Fexofenadine
4.3.5. Levocetirizine
4.3.6. Loratadine
4.4. Pipeline Analysis: Antihistamines Market
4.4.1. Phase III (Forecast till 2026)
4.4.2. Phase II (Tabular Representation)

Chapter 5. Global Antihistamines Market, by Application, 2016–2026 (US$ Mn)
5.1. Overview
5.2. Allergic Rhinitis
5.3. Conjunctivitis
5.4. Urticaria
5.5. Atopic Dermatitis
5.6. Anaphylaxis
5.7. Others (Angioedema, Pruritus, and others)

Chapter 6. Global Antihistamines Market, by Geography, 2016–2026 (US$ Mn)
6.1. Overview
6.2. North America Antihistamines Market, 2016–2026 (US$ Mn)
6.2.1. North America Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.2.2. North America Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.2.3. North America Antihistamines Market, by Country, 2016–2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Antihistamines Market, 2016–2026 (US$ Mn)
6.3.1. Europe Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.3.2. Europe Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.3.3. Europe Antihistamines Market, by Country/Region, 2016–2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Antihistamines Market, 2016–2026 (US$ Mn)
6.4.1. Asia Pacific Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.4.2. Asia Pacific Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.4.3. Asia Pacific Antihistamines Market, by Country/Region, 2016–2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Antihistamines Market, 2016–2026 (US$ Mn)
6.5.1. Latin America Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.5.2. Latin America Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.5.3. Latin America Antihistamines Market, by Country/Region, 2016–2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Antihistamines Market, 2016–2026 (US$ Mn)
6.6.1. MEA Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.6.2. MEA Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.6.3. MEA Antihistamines Market, by Region, 2016–2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Profiles
7.1. Bayer AG
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Almirall S.A.
7.3. Johnson & Johnson
7.4. AstraZeneca plc
7.5. Novartis AG
7.6. Pfizer, Inc.
7.7. Sanofi SA
7.8. Boehringer Ingelheim GmbH
7.9. Merck & Co., Inc.
7.10. Akorn, Inc.
7.11. Teva Pharmaceutical Industries Ltd.
7.12. Celgene Corporation
7.13. F. Hoffman-La Roche

FIG. 1 Antihistamines Market: Research Methodology
FIG. 2 Global Antihistamines Market, by Antihistamines Type, 2017 (Value %)
FIG. 3 Global Antihistamines Market, by Application Type, 2017 (Value %)
FIG. 4 Global Antihistamines Market, by Geography, 2017 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2017
FIG. 6 Global Alimemazine Market, 2016 – 2026 (US$ Mn)
FIG. 7 Global Chlorphenamine Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Clemastine Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Cyproheptadine Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Hydroxyzine Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Ketotifen Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Promethazine Market, 2016 – 2026 (US$ Mn)
FIG. 13 Global Others Market, 2016 – 2026 (US$ Mn)
FIG. 14 Global Acrivastine Market, 2016 – 2026 (US$ Mn)
FIG. 15 Global Cetirizine Market, 2016 – 2026 (US$ Mn)
FIG. 16 Global Desloratadine Market, 2016 – 2026 (US$ Mn)
FIG. 17 Global Fexofenadine Market, 2016 – 2026 (US$ Mn)
FIG. 18 Global Levocetirizine Market, 2016 – 2026 (US$ Mn)
FIG. 19 Global Antihistamines Market for Allergic Rhinitis Treatment, 2016 – 2026 (US$ Mn)
FIG. 20 Global Antihistamines Market for Conjunctivitis Treatment, 2016 – 2026 (US$ Mn)
FIG. 21 Global Antihistamines Market for Urticaria Treatment, 2016 – 2026 (US$ Mn)
FIG. 22 Global Antihistamines Market for Atopic Dermatitis Treatment, 2016 – 2026 (US$ Mn)
FIG. 23 Global Antihistamines Market for Anaphylaxis Treatment, 2016 – 2026 (US$ Mn)
FIG. 24 Global Antihistamines Market for Others Treatment, 2016 – 2026 (US$ Mn)
FIG. 25 U.S Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 26 Canada Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 27 U.K. Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 28 Germany Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 29 Rest of the Europe Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 30 China Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 31 Japan Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 32 Rest of Asia Pacific Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 33 Brazil Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 34 Mexico Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 35 Rest of Latin America Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 36 GCC Antihistamines Market, 2016 – 2026 (US$ Mn)
FIG. 37 Rest of Middle East & Africa Antihistamines Market, 2016 – 2026 (US$ Mn)

TABLE 1 Market Competition Assessment: Antihistamines, by Key Players
TABLE 2 Global Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
TABLE 3 Global First Generation Antihistamines Market, by Drugs, 2016 - 2026 (US$ Mn)
TABLE 4 Global Second Generation Antihistamines Market, by Drugs, 2016 - 2026 (US$ Mn)
TABLE 5 Global Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 6 Global Antihistamines Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 7 North America Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
TABLE 8 North America Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 9 North America Antihistamines Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 10 Europe Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
TABLE 11 Europe Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 12 Europe Antihistamines Market, by Country/Region, 2016 - 2026 (US$ Mn)
TABLE 13 Asia Pacific Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
TABLE 14 Asia Pacific Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 15 Asia Pacific Antihistamines Market, by Country/Region, 2016 - 2026 (US$ Mn)
TABLE 16 Latin America Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
TABLE 17 Latin America Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 18 Latin America Antihistamines Market, by Country/Region, 2016 - 2026 (US$ Mn)
TABLE 19 Middle East & Africa Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
TABLE 20 Middle East & Africa Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 21 Middle East & Africa Antihistamines Market, by Region, 2016 - 2026 (US$ Mn)
TABLE 22 Bayer AG: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 23 Almirall S.A.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 24 Johnson & Johnson Limited: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 25 Astra Zeneca plc: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 26 Novartis AG: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 27 Pfizer, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 28 Sanofi SA: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 29 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 30 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 31 Akron, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 32 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 33 Celgene Corporation: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 34 F. Hoffman-La Roche: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients